Significant drop in veterinary antibiotics sales across Europe
Randox Food Diagnostics recently reported that the European Parliament has banned the use of antibiotics that are important for human medicine use on animals, and is prohibiting any antimicrobials in livestock without a vet prescription. The new legislation, that is to become law by 2022, states that antimicrobials cannot be used to improve performance or compensate for poor animal conditions.
The European Medicines Agency (EMA) have now documented a significant drop in overall veterinary antibiotic sales across Europe. The EMA recognise that the reduction highlights the efforts made by the European Union (EU) and various stakeholders, promoting prudent use of antibiotics in the animal sector and its positive impact. The reduction of antibiotic use in food-producing animals is a key pillar to the EUs One Health Action Plan against Antimicrobial Resistance (AMR), according to a report conducted by the University of Minnesota.
30 countries in total submitted data between 2011 and 2016. German antibiotic sales dropped by 58%. However, whilst the majority of countries saw a drop in sales, six countries reported an increase of more than 5%. Germany’s implementation of an antibiotic minimising programme has helped the country to minimise antibiotic use, by requiring farmers raising cattle, pigs, chickens, or turkeys to report the frequency of antibiotic treatment on their farm every 6 months. If animal treatment frequency is above the median of all farms, operators must evaluate their usage with a veterinarian.
This major step forward in public health has a direct impact on the environment and food. Randox Food Diagnostics recognise the importance of improving the global food safety chain, and continue to transform the landscape by developing high quality revolutionary screening products. Our reliable and economic testing methods enable the user to detect multiple drug and toxin residues from a single sample, including antimicrobials, growth promoting compounds, synthetic steroids, anthelmintics and coccidiostats. With an expanding range of 37 ELISAs, 21 multiplex screening arrays and 20 enzymatic/colourmetric reagents, our trusted solutions ensure that better science means safer food.
For any questions, email us directly at: firstname.lastname@example.org
Randox Laboratories is representing our ever-growing knowledge economy this week at the world’s largest medical exhibition, the Medica World Forum for Medicine International Trade Fair.
Randox is joining a host of other healthcare exhibitors from over 120 countries, on over 1.3million square feet of exhibition space at the Düsseldorf Fairgrounds in Germany. The event, which runs for four days between Monday and Thursday, will showcase the latest developments across a range of medical sectors including Laboratory Equipment, Diagnostics, Physiotherapy and Orthopedic Technology, Communication and Information Technology, and Medical Services and Publications.
The Medica Trade Fair provides Randox and over 4800 other exhibitors the opportunity to showcase new and existing diagnostic capabilities to the world. With key manufacturing sites in Co. Antrim and Co. Donegal, in India and just outside Washington DC, Randox Laboratories diagnostics are already used and trusted by medical professionals across the globe, and are also available to the general public at Randox Health Clinics in Northern Ireland and in London.
Exporting to 145 countries, and with more tests in development than any other diagnostics company, Randox is a leading innovator in the fight against illnesses such as cancer, coronary heart disease and diabetes, and is dedicated to saving and improving lives around the globe through preventative healthcare and early diagnosis.
At the Medica Fair, 30 members of the Randox team, including Senior Managers and Expert Scientists from a range of disciplines, will showcase to over 130,000 visitors a range of novel diagnostic tests for conditions such as diabetes, aspirin resistance, cardiovascular risk and gastric problems – highlighting just how our home-grown scientists are benefiting lives across the globe.
John Lamont, Chief Scientist at Randox Laboratories, commented:
“As a firmly established event in the medical calendar, The Medica Fair is the perfect opportunity for Randox to display to the global healthcare industry how our world-class diagnostics make a difference in the lives of so many patients across the world. From routine cholesterol checks to complex tests used in diagnosis of respiratory conditions, Randox is working behind the scenes from the moment you provide a blood sample to your GP.
In addition to our range of current extensive capabilities, we are also excited to share some new tests for aspirin resistance, cardiovascular risk and gastric problems at the Medica Fair, the hub of the medical trade. Randox is at the forefront of life-changing research and development in the medical industry and we are proud that we can show the Medica audience how our innovative diagnostic tests are paving the way for the future of healthcare.”
The Medica World Forum for Medicine International Trade Fair runs from Monday 16th to Thursday 19th November, and Randox will be in Hall 3 at Stand A08.